Cropper(James) PLC
07 March 2006
James Cropper PLC ('the Company')
Sale of shares by James Cropper PLC Pension Scheme ('the Scheme')
In late 2004 the trustees of the Scheme undertook a review of the Scheme's
Investment Strategy inconjunction with its advisers. The aim of the review was
to align the Scheme's assets with the changing age profile of its membership
resulting from the closure of the Scheme to new membership in 1999. As a result
of this review the trustees have embarked upon a Strategy that will
progressively increase the proportion of its funds held in bonds with a
consequent reduction in equities.
The Company was notified on 7 March 2006 that the Scheme had sold 10,000
ordinary shares of 25 pence each in the Company ('Ordinary Shares') at a price
of 157 pence per Ordinary Share. Following this disposal the Scheme now holds
231,000 Ordinary Shares representing 2.76 per cent of the Company's issued
ordinary share capital.
Two executive directors Mr John Malcolm Denman and Mr Nigel Anthony Read are
trustees of the Scheme and are therefore deemed to have a non-beneficial
interest in the Scheme.
7 March 2006
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.